EdgarLookup

Celldex Therapeutics, Inc. — SC 13G/A Filings

72 SC 13G/A filings on record

This page lists all SC 13G/A filings submitted to the SEC by Celldex Therapeutics, Inc. (CLDX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Celldex Therapeutics, Inc. has filed 72 SC 13G/A documents with the SEC since 2007. To view all SEC filings by Celldex Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-K405 10-Q 10-Q/A 144 3 4 4/A 424B1 424B2 424B3 424B5 425 5 8-A12G 8-A12G/A 8-K 8-K/A ARS CORRESP CT ORDER D DEF 14A DEFA14A DEFR14A DEL AM EFFECT NT 10-K NT 10-Q POS AM PRE 14A REGDEX S-3 S-3/A S-3ASR S-3MEF S-4 S-4/A S-8 S-8 POS SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
SC 13G/A 0000902664-24-006640 Nov 14, 2024
SC 13G/A SC 13G/A 0001580642-24-006951 Nov 14, 2024
SC 13G/A CELLDEX THERAPEUTICS, INC. 0000902664-24-006486 Nov 14, 2024
SC 13G/A 0001172661-24-004709 Nov 13, 2024
SC 13G/A 0000315066-24-002724 Nov 12, 2024
SC 13G/A SEC SCHEDULE 13G 0000902219-24-000467 Nov 8, 2024
SC 13G/A CELLDEX THERAPEUTICS, INC. 0000902664-24-001707 Feb 14, 2024
SC 13G/A CELLDEX THERAPEUTICS, INC. 0000902664-24-001565 Feb 14, 2024
SC 13G/A SCHEDULE 13G/A 0001104659-24-020559 Feb 13, 2024
SC 13G/A 0000315066-24-001069 Feb 9, 2024
SC 13G/A SEC SCHEDULE 13G 0000902219-24-000057 Feb 8, 2024
SC 13G/A 0001086364-24-004828 Jan 26, 2024
SC 13G/A SEC SCHEDULE 13G 0000902219-23-000024 May 10, 2023
SC 13G/A SC 13G/A 0001140361-23-006807 Feb 14, 2023
SC 13G/A CELLDEX THERAPEUTICS, INC. 0000902664-23-001725 Feb 14, 2023
SC 13G/A SCHEDULE 13G/A 0001104659-23-015586 Feb 9, 2023
SC 13G/A 0000315066-23-001436 Feb 9, 2023
SC 13G/A 0001306550-23-005854 Feb 1, 2023
SC 13G/A SC 13G/A 0001104659-22-023142 Feb 14, 2022
SC 13G/A CELLDEX THERAPEUTICS, INC. 0000902664-22-001595 Feb 14, 2022
SC 13G/A CELLDEX THERAPEUTICS, INC. 0000902664-22-001350 Feb 10, 2022
SC 13G/A 0000315066-22-000887 Feb 9, 2022
SC 13G/A COWEN FINANCIAL PRODUCTS LLC 0001085146-22-000165 Jan 18, 2022
SC 13G/A COWEN FINANCIAL PRODUCTS LLC 0001085146-22-000137 Jan 14, 2022
SC 13G/A SC 13G/A 0001193125-21-041686 Feb 12, 2021
SC 13G/A 0001493152-21-003530 Feb 12, 2021
SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-21-000324 Feb 11, 2021
SC 13G/A CELLDEX THERAPEUTICS, INC. 0000902664-21-001119 Feb 11, 2021
SC 13G/A 0001037389-21-000083 Feb 10, 2021
SC 13G/A SC 13G/A 0001193125-19-039738 Feb 14, 2019
SC 13G/A 0000932471-19-004430 Feb 11, 2019
SC 13G/A 0000215457-18-005851 Jul 10, 2018
SC 13G/A 0000315066-18-001910 May 10, 2018
SC 13G/A SC 13G/A 0001193125-18-041541 Feb 13, 2018
SC 13G/A 0000315066-18-001108 Feb 13, 2018
SC 13G/A 0000932471-18-003136 Feb 9, 2018
SC 13G/A 0000215457-18-003876 Jan 29, 2018
SC 13G/A 0000315066-17-002938 Dec 11, 2017
SC 13G/A 0000315066-17-002340 May 10, 2017
SC 13G/A 0000315066-17-001529 Feb 14, 2017
SC 13G/A SCHEDULE 13G 0000728889-17-000324 Feb 14, 2017
SC 13G/A 0000932471-17-001145 Feb 10, 2017
SC 13G/A AMENDED SCHEDULE 13G 0001445546-17-000671 Jan 31, 2017
SC 13G/A 0000353480-17-000234 Jan 23, 2017
SC 13G/A 0000315066-16-004970 Feb 12, 2016
SC 13G/A 0000932471-16-011546 Feb 10, 2016
SC 13G/A SCHEDULE 13G 0000728889-16-002081 Feb 2, 2016
SC 13G/A 0000215457-16-002379 Jan 26, 2016
SC 13G/A 0000315066-15-001781 Feb 13, 2015
SC 13G/A 0000932471-15-004527 Feb 10, 2015